Yasmin Genevieve Hernandez-Barco, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis, Chronic | 2 | 2024 | 282 | 1.280 |
Why?
|
Pancreatic Neoplasms | 9 | 2024 | 5446 | 0.800 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2023 | 195 | 0.750 |
Why?
|
Pancreatic Cyst | 1 | 2024 | 372 | 0.690 |
Why?
|
Adenocarcinoma, Mucinous | 3 | 2024 | 523 | 0.670 |
Why?
|
Toll-Like Receptor 4 | 4 | 2010 | 588 | 0.660 |
Why?
|
Carcinoma, Pancreatic Ductal | 6 | 2024 | 1759 | 0.630 |
Why?
|
Cysts | 1 | 2023 | 685 | 0.600 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 957 | 0.370 |
Why?
|
Gastroenterology | 3 | 2021 | 593 | 0.350 |
Why?
|
Pregnancy Complications | 1 | 2024 | 2971 | 0.340 |
Why?
|
Dinoprostone | 3 | 2010 | 597 | 0.320 |
Why?
|
Colitis | 3 | 2010 | 1238 | 0.280 |
Why?
|
Epidermal Growth Factor | 1 | 2010 | 697 | 0.280 |
Why?
|
Pancreas | 3 | 2024 | 1699 | 0.270 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2188 | 0.230 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2024 | 322 | 0.220 |
Why?
|
Dextran Sulfate | 3 | 2010 | 256 | 0.180 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 520 | 0.180 |
Why?
|
Endosonography | 1 | 2023 | 626 | 0.160 |
Why?
|
Cholangitis | 1 | 2020 | 110 | 0.160 |
Why?
|
Device Approval | 1 | 2021 | 164 | 0.160 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 2535 | 0.150 |
Why?
|
Pancreaticoduodenectomy | 1 | 2020 | 515 | 0.140 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2010 | 1655 | 0.130 |
Why?
|
Glycoproteins | 3 | 2010 | 2200 | 0.110 |
Why?
|
Neuroendocrine Tumors | 1 | 2020 | 659 | 0.110 |
Why?
|
Cyclooxygenase 2 | 3 | 2010 | 597 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 18063 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 948 | 0.110 |
Why?
|
Triage | 1 | 2020 | 995 | 0.110 |
Why?
|
Equipment Design | 1 | 2021 | 3489 | 0.110 |
Why?
|
Patient Care Team | 1 | 2024 | 2516 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1205 | 0.100 |
Why?
|
Retrospective Studies | 9 | 2024 | 81659 | 0.090 |
Why?
|
Jejunal Diseases | 1 | 2011 | 45 | 0.090 |
Why?
|
Ileal Diseases | 1 | 2011 | 70 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3618 | 0.090 |
Why?
|
Azoxymethane | 1 | 2010 | 32 | 0.090 |
Why?
|
Humans | 23 | 2024 | 767040 | 0.080 |
Why?
|
Prostaglandins | 1 | 2010 | 398 | 0.080 |
Why?
|
Intestinal Mucosa | 2 | 2010 | 3043 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2420 | 0.070 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6966 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2666 | 0.070 |
Why?
|
Mucous Membrane | 1 | 2010 | 659 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3786 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2010 | 14476 | 0.070 |
Why?
|
Disease Progression | 2 | 2024 | 13646 | 0.060 |
Why?
|
Phenotype | 1 | 2024 | 16718 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2010 | 10455 | 0.060 |
Why?
|
Length of Stay | 1 | 2019 | 6489 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12790 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 16036 | 0.060 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3236 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2011 | 888 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8048 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.060 |
Why?
|
Female | 11 | 2024 | 396660 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3804 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6360 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3112 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3234 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15851 | 0.050 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2217 | 0.050 |
Why?
|
Aged | 8 | 2024 | 171319 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4560 | 0.050 |
Why?
|
Pregnancy | 1 | 2024 | 30238 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2010 | 3698 | 0.050 |
Why?
|
Up-Regulation | 1 | 2010 | 4143 | 0.050 |
Why?
|
Middle Aged | 8 | 2024 | 223233 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8736 | 0.040 |
Why?
|
Equipment Safety | 1 | 2021 | 250 | 0.040 |
Why?
|
Antibodies, Neutralizing | 1 | 2010 | 2011 | 0.040 |
Why?
|
Regeneration | 1 | 2009 | 1523 | 0.040 |
Why?
|
Male | 10 | 2024 | 364203 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5947 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10815 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.040 |
Why?
|
Gene Frequency | 1 | 2024 | 3621 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2010 | 22361 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 2009 | 1924 | 0.030 |
Why?
|
Needles | 1 | 2020 | 461 | 0.030 |
Why?
|
Fibrosis | 1 | 2024 | 2078 | 0.030 |
Why?
|
Signal Transduction | 2 | 2010 | 23621 | 0.030 |
Why?
|
Cell Line | 1 | 2010 | 15567 | 0.030 |
Why?
|
Mice | 4 | 2010 | 81912 | 0.030 |
Why?
|
Genetic Loci | 1 | 2024 | 2629 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14672 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223317 | 0.030 |
Why?
|
Colonoscopy | 1 | 2022 | 1409 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 59980 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1672 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9245 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1135 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 89046 | 0.020 |
Why?
|
Animals | 4 | 2010 | 168965 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39317 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18330 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10622 | 0.020 |
Why?
|
Inflammation | 1 | 2009 | 10869 | 0.020 |
Why?
|
Bacterial Translocation | 1 | 2009 | 74 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12986 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59548 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54886 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1751 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21526 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2009 | 960 | 0.020 |
Why?
|
Chemokines | 1 | 2009 | 963 | 0.010 |
Why?
|
Risk Factors | 3 | 2020 | 74886 | 0.010 |
Why?
|
Life Style | 1 | 2014 | 3931 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 40154 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4881 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2710 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5311 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10582 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2429 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15424 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2009 | 3468 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5203 | 0.010 |
Why?
|
Macrophages | 1 | 2009 | 5785 | 0.010 |
Why?
|
Cytokines | 1 | 2009 | 7446 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8628 | 0.010 |
Why?
|
United States | 1 | 2021 | 72971 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 24299 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10254 | 0.010 |
Why?
|